Cardio-oncological management of patients.
Cancer drugs
Cardiovascular toxicity
Imaging
Prevention
Risk
Treatment
Journal
Seminars in oncology
ISSN: 1532-8708
Titre abrégé: Semin Oncol
Pays: United States
ID NLM: 0420432
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
10
01
2019
accepted:
11
11
2019
pubmed:
1
12
2019
medline:
17
1
2020
entrez:
1
12
2019
Statut:
ppublish
Résumé
Session III of the Second International Colloquium on Cardio-Oncology focused on the diagnosis, management, and prevention of cardiovascular toxicity of cancer drugs. With a large menu of biomarkers and imaging modalities available to the cardio oncologist, there continues to be no consensus regarding the best use of each modality alone and in combination and whether we can actually prevent early and late cardiotoxicity using these tests to guide a preventive strategy. It has become increasingly clear that early diagnosis and intervention leads to less late cardiotoxicity and fewer cardiac-related events. This can be accomplished by taking a thorough history and performing a goal directed physical examination coupled with use of biomarkers and imaging studies. This session attempted to provide rationale for a current and integrated approach to these issues.
Identifiants
pubmed: 31784042
pii: S0093-7754(19)30009-0
doi: 10.1053/j.seminoncol.2019.11.002
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
408-413Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.